GlassScriptPhysician profile
Ericka L Broussard
NPI 1962688077
$5,728.32
in general payments reported to CMS, 2019-2025
33 companies · $1,740 in 2025
The $1,740 reported for 2025 was more than what 92% of Adult Health (Nurse Practitioner) providers received nationally (typical 2025 total: $182).
See the full distribution for Adult Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $702 · 2022: $997 · 2023: $1,110 · 2024: $1,178 · 2025: $1,740.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,022 · Education: $7.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,021.51 |
| Education | $7.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,512.99 | 2021-2025 | |
| Currax Pharmaceuticals LLC | $468.11 | 2021-2025 | Contrave, Onzetra Xsail, Nexlizet |
| Pfizer INC. | $431.18 | 2021-2025 | |
| Sumitomo Pharma America, INC. | $418.17 | 2023-2025 | Myfembree, Gemtesa |
| Axsome Therapeutics, INC. | $363.31 | 2025 | Auvelity |
| Astellas Pharma US INC | $361.46 | 2023-2025 | Veozah, Myrbetriq |
| Exeltis, USA INC. | $208.37 | 2022-2024 | Slynd |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $177.51 | 2024-2025 | Caplyta |
| Mayne Pharma Commercial LLC | $177.37 | 2022-2025 | |
| Bausch Health US, LLC | $168.31 | 2022-2025 | Aplenzin, Wellbutrin |
| Novo Nordisk INC | $164.52 | 2021-2022 | |
| Myovant Sciences INC. | $150.23 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $149.37 | 2021-2025 | |
| E.R. Squibb & Sons, L.L.C. | $105.65 | 2025 | Cobenfy |
| Avion Pharmaceuticals | $100.99 | 2021-2022 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Sage Therapeutics, LLC | $83.14 | 2025 | Zurzuvae |
| Amgen INC. | $73.58 | 2022-2025 | Evenity, Prolia |
| Organon LLC | $64.33 | 2024-2025 | Nexplanon |
| Daiichi Sankyo INC. | $63.34 | 2022 | |
| Evofem Biosciences, INC. | $62.99 | 2021-2022 | |
| Millicent US INC | $55.84 | 2025 | Intrarosa, Femlyv |
| Lundbeck LLC | $54.56 | 2023 | Vyepti |
| Hologic Sales and Service, LLC | $47.29 | 2023-2024 | Aptima |
| Supernus Pharmaceuticals, INC. | $42.23 | 2025 | Qelbree |
| Mylan Pharmaceuticals INC. | $37.21 | 2022 | |
| Biohaven Pharmaceutical Holding Company LTD. | $35.39 | 2022 | |
| Merck Sharp & Dohme LLC | $27.63 | 2022-2024 | Gardasil, Gardasil 9 |
| Upsher-Smith Laboratories LLC | $25.31 | 2021 | |
| Pacira Pharmaceuticals Incorporated | $23.20 | 2024 | Exparel, Zilretta, Iovera |
| Scynexis, INC. | $20.63 | 2022 | |
| Alkermes, INC. | $19.51 | 2024 | Aristada, Lybalvi |
| Braeburn INC. | $18.81 | 2024 | Brixadi |
| Biogen, INC. | $15.79 | 2024 | Zurzuvae |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ericka Broussard listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.